Composition of a new Working Group on Dosimetry in Nuclear Medicine Therapy – Molecular Therapy– EFOMP Policy Statement 19
Publication Date: Jul 28th, 2022 11:20, Category: EFOMP Announcements
After a successful call on new Working Group (WG) entitled “Dosimetry in Nuclear Medicine Therapy – Molecular Therapy”, EFOMP governing committee is proud to announce, that the final composition was approved according to EFOMP procedures
(see EFOMP operational guide). The WG is ready to operate under Science Committee from August 2022 to September 2023. The chair of the WG is Manuel Bardiès (France).
More detailed information about composition of the WG composition you may find in an attached file.
Composition of PS19 WG Size: 112,66 KB